Table 3.
Clinical response at EOI∗ | MRD negative at EOI† (N = 13) |
---|---|
IRC assessed, n (%) | |
CR | 11 (84.6) |
PR | 1 (7.7) |
NA | 1 (7.7) |
Investigator assessed, n (%) | |
CR | 11 (84.6) |
PR | 1 (7.7) |
NA | 1 (7.7) |
NA, not available.
Assessed according to the modified Lugano 2014 criteria.
Patients were MRD positive at baseline and had repeated testing at EOI; all were negative at EOI.